Impax Asset Management Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-65,000
Closed -$3.85M – 289
2026
Q1
$3.85M Sell
65,000
-65,000
-50% -$4.22M 0.03% 223
2025
Q4
$8.02M Buy
130,000
+20,000
+18% +$1.22M 0.05% 169
2025
Q3
$6.86M Hold
110,000
– – 0.04% 169
2025
Q2
$8.78M Sell
110,000
-25,000
-19% -$2.09M 0.05% 152
2025
Q1
$11.6M Hold
135,000
– – 0.07% 133
2024
Q4
$10.5M Sell
135,000
-35,000
-21% -$2.72M 0.05% 157
2024
Q3
$12.3M Hold
170,000
– – 0.05% 146
2024
Q2
$11.7M Hold
170,000
– – 0.05% 149
2024
Q1
$12.3M Hold
170,000
– – 0.05% 152
2023
Q4
$10.4M Hold
170,000
– – 0.04% 172
2023
Q3
$9.72M Hold
170,000
– – 0.04% 162
2023
Q2
$10.1M Hold
170,000
– – 0.04% 158
2023
Q1
$10.6M Hold
170,000
– – 0.04% 153
2022
Q4
$10.6M Buy
170,000
+50,000
+42% +$2.87M 0.05% 154
2022
Q3
$5.98M Buy
+120,000
New +$6.64M 0.03% 181

Other funds holding PBH

Impax Asset Management Group's PBH Position: Q2 2026 in Review

Impax Asset Management Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 65,000 shares — an estimated $3.85M sold.

Impax Asset Management Group first reported a position in PBH in Q3 2022 and held it in 15 quarters. The position peaked at $12.3M in Q1 2024. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Impax Asset Management Group reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Impax Asset Management Group sold 65,000 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.85M.
  • Impax Asset Management Group first reported a position in Prestige Consumer Healthcare in Q3 2022 and held it in 15 quarters.
  • Impax Asset Management Group's Prestige Consumer Healthcare position peaked at $12.3M in Q1 2024.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.